Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft-vs.-Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)
2011 ◽
Vol 17
(2)
◽
pp. S291
2020 ◽
Vol 26
(2)
◽
pp. 316-322
2013 ◽
Vol 19
(10)
◽
pp. 1453-1458
◽
2007 ◽
Vol 21
(2)
◽
pp. 207-213
◽